Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Roche for the Transformative Bio-Hermes-002 Study
Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...
Investing6d
UBS lifts Roche stock rating to Buy, raises target to CHF338
Roche's stock price is expected to reflect the anticipated ... sustained performance in the Diagnostics segment, and cost management. This article was generated with the support of AI and reviewed ...
Investing5d
UBS lifts Roche stock rating to Buy, raises target to CHF338
Roche's stock price is expected to reflect the anticipated performance ... sustained performance in the Diagnostics segment, and cost management. This article was generated with the support of AI and ...
Yahoo Finance4d
Roche Holding AG (RHHBY)
In this article, we are going to take a look at where Roche Holding AG (OTC:RHHBY) stands against other best annual dividend stocks to buy ... as the Swiss drugs and diagnostics company said ...
Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Roche initiated with an Equal Weight at Morgan Stanley
Morgan Stanley initiated coverage of Roche (RHHBY) with an Equal Weight rating and CHF 305 price target The firm sees the end of Roche’s ...
Investing5d
Roche Holding Ltd DRC (RHHBY)
Assess today's live Roche Holding Ltd DRC (RHHBY) share price, performance and insights using our live OTC Markets: RHHBY stock exchange data. Analyse the historical data and Roche Holding Ltd DRC ...